
R&D / Formulation
Pharmaceutical formulation development support
Structuring an immediate-release tablet development so trial data leads to a scalable, documented formulation.
Illustrative use caseCapability
Structured research and development support that moves a product idea through pre-formulation, formulation, analytical and process work to a transfer-ready package.


We plan and coordinate development work so that each stage produces the data the next stage needs. That means defining the target product profile early, agreeing which studies are critical, and keeping development reports in a form that manufacturing, quality and regulatory teams can use later.
Laboratory and pilot-scale studies are carried out by qualified research partners selected for the dosage form and technology involved. DGXPComplianceLab frames the development plan, reviews the data and keeps the documentation trail coherent from first experiment to technology transfer.
Each activity shows who performs it. We do not claim facilities we do not own.
DGXP-led Led by the DGXPComplianceLab team Partner-coordinated Performed by a qualified partner, coordinated by us
Reference product characterisation, literature and patent landscape, target product profile.
API physicochemical characterisation, solubility, polymorphism and excipient compatibility studies.
Prototype design, trial batches and optimisation against critical quality attributes.
Method development for assay, related substances, dissolution and identification.
Unit-operation selection, critical process parameters and design-space thinking.
Primary pack selection, moisture/light protection and compatibility rationale.
Protocol design aligned to ICH Q1A(R2), pull schedules and trend review.
Scale-up rationale, equipment equivalence and engineering batch planning.
Transfer protocols, knowledge packages and receiving-site readiness.
Post-approval changes, line extensions and continuous improvement studies.
Illustrative project example — not a description of a specific client project.
Illustrative use cases showing how this capability is typically applied.

R&D / Formulation
Structuring an immediate-release tablet development so trial data leads to a scalable, documented formulation.
Illustrative use case
Manufacturing / R&D
Reducing yield loss and in-process rejections in an oral solid dosage process.
Illustrative use case
Regulatory / Manufacturing / Quality
Building a complete documentation set for transferring a product between sites.
Illustrative use caseEvery engagement follows the same eight steps, scaled to the size and risk of the project.
Understand business and technical requirements.
Assess scientific, technical, regulatory and operational requirements.
Design the appropriate solution.
Identify appropriate internal and external capabilities and partners.
Coordinate and execute the project.
Test, verify, qualify or validate where applicable.
Create technical, quality and regulatory documentation.
Monitor, optimise and continuously improve.
From prototype to a robust, scalable formulation: dosage-form design, optimisation and the process knowledge that makes…
Research and development studies coordinated with contract research organisations, with DGXPComplianceLab managing scop…
Analytical testing, method work and stability programmes arranged with contract laboratories, with clear lines between …
Contract manufacturing and contract development-and-manufacturing support, coordinated through qualified partner organi…
Laboratory and pilot work is performed by qualified partner organisations selected for the product and technology. DGXPComplianceLab leads planning, data review, documentation and coordination.
The target product or reference product, intended market(s), dosage form, expected scale and any existing development data. A short requirement note is enough for a first discussion.
Yes. We start with a gap assessment of the existing data and reports, then agree what has to be repeated, completed or documented.
Share the product, stage and timeline. Capability is confirmed after technical assessment and partner availability.